Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial - Wikidata - wikimedia - TriplyDB

Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial

Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial

http://www.wikidata.org/entity/Q36764757

about

Visual outcome of mega-dose intravenous corticosteroid treatment in non-arteritic anterior ischemic optic neuropathy - retrospective analysis.Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.Macular Evaluation wıth Spectral Domain Type Optic Coherence Tomography in Eyes with Acute Nonarteritic Ischemic Optic Neuropathy at the Presentation Visit.A Single Intravitreal Injection of Ranibizumab Provides No Neuroprotection in a Nonhuman Primate Model of Moderate-to-Severe Nonarteritic Anterior Ischemic Optic Neuropathy.Efficacy of intravitreal ranibizumab injection in acute nonarteritic ischemic optic neuropathy: a long-term follow up.An unusual presentation of nonarteritic ischemic optic neuropathy with subretinal fluid treated with intravitreal bevacizumab Use of Intravitreal Dexamethasone in a Case of Anterior Ischemic Optic Neuropathy.Single intravitreal aflibercept injection for unilateral acute nonarteritic ischemic optic neuropathy.High-dose intravenous pulse steroid therapy for optic disc swelling and subretinal fluid in non-arteritic anterior ischemic optic neuropathy.Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management.

P2860

Q33595516-A2340756-19D4-45A6-9570-C31620F41657 Q34905119-8877956B-A07D-4686-A90D-8F9324AC3A32 Q36344114-3D9716EB-147F-46FD-A8B5-CD3B7C5010F4 Q36347398-35F1938A-9B1B-40FD-8DDF-4C4435588246 Q37226587-5E56D8CA-9BB1-49D5-B82E-EE11C8AFECC8 Q39876374-BF39E899-4C86-41AA-B948-D56BE7059B24 Q41112112-13520394-403F-42DA-AD14-CB1E73377B7D Q42062641-01762F32-50B6-40CB-B4A8-A3187BFBC1B5 Q42317011-77290B02-C429-466C-91DB-5695E39A72B7 Q42370614-01447E15-9A8B-4A9D-9AEC-B90B9DC5919C

P2860

Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial

http://www.wikidata.org/entity/Q36764757

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Intravitreal bevacizumab for t ...... europathy: a prospective trial

@ast

Intravitreal bevacizumab for t ...... europathy: a prospective trial

@en

type

label

Intravitreal bevacizumab for t ...... europathy: a prospective trial

@ast

Intravitreal bevacizumab for t ...... europathy: a prospective trial

@en

prefLabel

Intravitreal bevacizumab for t ...... europathy: a prospective trial

@ast

Intravitreal bevacizumab for t ...... europathy: a prospective trial

@en

P1433

Q36764757-B313C355-3082-42B8-A253-5C115BD06F90

P1476

Q36764757-2EC4BB0A-26A7-4AEF-8D84-9EA1DCC2E5D3

P2093

Q36764757-4ADE9ED6-6855-4F3C-B364-A8A5B1ECF127

Q36764757-50C143D5-39A9-4681-97C4-5B184F762854

Q36764757-E436AC44-DE9A-4462-BCFB-42351352CBCB

P2860

Q36764757-00B9A337-B703-42CB-99CD-331C0E2F3E47

Q36764757-1295AE57-354C-40D8-958D-C196D8B0B826

Q36764757-1AEC8130-619D-4896-BD08-79DF72426219

Q36764757-2167010D-117F-4CEB-BFBA-4D13176F1C87

Q36764757-2B8527DF-B7B9-4DA1-87F3-0F8798135527

Q36764757-2E1E65B8-5F0C-4559-BF9A-E65A597CEAE4

Q36764757-4E6DB697-2B62-4673-B648-F5753536DCA7

Q36764757-4F0A93DF-C102-432B-AA8B-AE3862B57F72

Q36764757-6D8C7696-CCD7-48F9-B4D8-49BF7E2A53D0

Q36764757-766BE07D-6ECF-4DBA-BE8B-5FE8D3E36853

P2888

Q36764757-35A8E76E-0157-4B06-A419-FE29950EE488

P304

Q36764757-61D2D577-0B44-4137-B363-F143F45384B4

P31

Q36764757-9B98DD78-B006-4DB2-87A0-A79A0EE67E40

P356

Q36764757-3793D580-A46C-4CB2-993C-41FF1AE09A00

P433

Q36764757-388013A5-2E97-4D78-A83E-08819BEE36D0

P478

Q36764757-9625EFF7-8999-4E81-A22A-7B1640F68F7D

P577

Q36764757-5A1706D0-0AC1-4B1E-97A7-9476403832A0

P5875

Q36764757-30D52C50-DED4-41F8-BFD3-A11EA0BF5A89

P698

Q36764757-1CB3775C-A5B4-4690-A267-F3E7CAE1493A

P921

Q36764757-8249C001-3C87-45B8-862E-3959C8BCE7D5

P932

Q36764757-EB0B1850-1F15-4E9B-ADA6-4DD19465E4CB

P356

P1433

P1476

Intravitreal bevacizumab for t ...... europathy: a prospective trial

@en

P2093

D B Rootman

http://www.w3.org/2001/XMLSchema#string

E A Margolin

http://www.w3.org/2001/XMLSchema#string

H S Gill

http://www.w3.org/2001/XMLSchema#string

P2860

Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy

The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

Pathogenesis of nonarteritic anterior ischemic optic neuropathy.

The natural history of non-arteritic anterior ischaemic optic neuropathy.

The effect of an intravitreal triamcinolone acetonide injection for acute nonarteritic anterior ischemic optic neuropathy.

Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome

Ischaemic optic neuropathy. The clinical profile and history.

Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.

Anterior ischemic optic neuropathy following intravitreal bevacizumab.

P2888

P304

538-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EYE.2012.296

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235391210

http://www.w3.org/2001/XMLSchema#string

P698

23370417

http://www.w3.org/2001/XMLSchema#string

P921

P932

3626001

http://www.w3.org/2001/XMLSchema#string